SPONSORED CONTENT The 340B program has morphed into a battlefield of rules, audits, and reporting. For smaller covered entities (CEs), […]
SPONSORED CONTENT Drug manufacturers defend their unrelenting campaign to reform the 340B program by citing, among other things, the need […]
SPONSORED CONTENT Time Inventory Management and 340B Clearinghouse The 340B program has experienced significant changes and disruptions over the past […]
SPONSORED CONTENT AI is everywhere—chatbots, smart assistants, predictive tools. But in 340B? The line between what’s useful and what’s just […]
SPONSORED CONTENT In today’s 340B environment, every claim counts. With increased oversight, tighter margins, and growing manufacturer restrictions, covered entities […]
SPONSORED CONTENT Across America, safety-net hospitals stand as a lifeline for millions. These institutions serve patients who often have nowhere […]
SPONSORED CONTENT News of an electronic medical record (EMR) conversion often brings about palpable anxiety and anticipation as a covered […]
SPONSORED CONTENT The purpose of the 340B drug pricing program remains a contested question between 340B providers and some in […]
SPONSORED CONTENT It’s easy to remember the days before 340B ESP, when setting up of a wholesale account was an […]
SPONSORED CONTENT Stay ahead of the latest developments shaping the 340B landscape with Ted Slafsky, Publisher and CEO of 340B […]